On March 31, 2022, Mary Ann Gray, Ph.D., informed the board of directors of Sarepta Therapeutics, Inc. that she has elected to not stand for re-election and will complete her term on the board at the conclusion of the company's 2022 annual meeting of stockholders. Dr. Gray's decision to not stand for re-election was not because of a disagreement with the company on any matter relating to the Company's operations, policies, or practices.